Atara Biotherapeutics logo

Atara Biotherapeutics share price today

(ATRA)

Atara Biotherapeutics share price is $13.33 & ₹1,135.69 as on 25 Dec 2024, 2.30 'hrs' IST

$13.33

1.13

(9.26%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Atara Biotherapeutics share price in Dollar and Rupees. Guide to invest in Atara Biotherapeutics from India. Also see the sentimental analysis on Indian investors investing in Atara Biotherapeutics. Get details on the Indian mutual funds that are investing in Atara Biotherapeutics. Get Analyst recommendations and forecasts along with all the Atara Biotherapeutics's financials.

Atara Biotherapeutics share price movements

  • Today's Low: $12.16
    Today's High: $13.39

    Day's Volatility :9.19%

  • 52 Weeks Low: $6.50
    52 Weeks High: $39.50

    52 Weeks Volatility :83.54%

Atara Biotherapeutics Returns

PeriodAtara Biotherapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
74.02%
-9.0%
0.0%
6 Months
61.38%
-4.6%
0.0%
1 Year
-4.77%
3.0%
0.0%
3 Years
-96.89%
0.0%
-21.1%

Atara Biotherapeutics Key Statistics

in dollars & INR

Previous Close
$12.2
Open
$12.37
Today's High
$13.39
Today's Low
$12.16
Market Capitalization
$76.8M
Today's Volume
$80.9K
52 Week High
$39.5
52 Week Low
$6.5
Revenue TTM
$62.4M
EBITDA
$-162.1M
Earnings Per Share (EPS)
$-25.32
Profit Margin
-290.2%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-2014.86%

How to invest in Atara Biotherapeutics from India?

It is very easy for Indian residents to invest directly in Atara Biotherapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Atara Biotherapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Atara Biotherapeutics or ATRA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Atara Biotherapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Atara Biotherapeutics shares which would translate to 0.064 fractional shares of Atara Biotherapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Atara Biotherapeutics, in just a few clicks!

Returns in Atara Biotherapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Atara Biotherapeutics investment value today

Current value as on today

₹97,453

Returns

₹2,547

(-2.55%)

Returns from Atara Biotherapeutics Stock

₹4,786 (-4.79%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Atara Biotherapeutics

-40%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Atara Biotherapeutics on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -40% less investors are searching Atara Biotherapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Atara Biotherapeutics

  • EcoR1 Capital, LLC

    8.14%

  • Redmile Group, LLC

    7.85%

  • Citadel Advisors Llc

    4.52%

  • Bank of America Corp

    3.54%

  • Vanguard Group Inc

    3.14%

  • Millennium Management LLC

    3.06%

Analyst Recommendation on Atara Biotherapeutics

Buy

    61%Buy

    30%Hold

    7%Sell

Based on 13 Wall street analysts offering stock ratings for Atara Biotherapeutics(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
4
4
4
Sell
1
1
1

Analyst Forecast on Atara Biotherapeutics

What analysts predicted

Upside of 22.53%

Current:

$13.33

Target:

$16.33

Insights on Atara Biotherapeutics

  • Price Movement

    In the last 7 days, ATRA stock has moved up by 34.2%
  • Increasing Revenue

    Revenue is up for the last 6 quarters, 957.0K → 40.19M (in $), with an average increase of 44.5% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -19.04M → -21.90M (in $), with an average decrease of 15.0% per quarter
  • ATRA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 31.6%
  • ATRA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 122.1%
  • Price to Sales

    ForATRA every $1 of sales, investors are willing to pay $1.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Atara Biotherapeutics Technicals Summary

Sell

Neutral

Buy

Atara Biotherapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Atara Biotherapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Atara Biotherapeutics Inc
8.73%
61.38%
-4.77%
-96.89%
-96.69%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-3.72%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Atara Biotherapeutics Inc
NA
NA
0.0
-1.51
-20.15
-0.57
NA
-23.3
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Atara Biotherapeutics Inc
Buy
$76.8M
-96.69%
NA
-290.2%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Atara Biotherapeutics

we launched atara biotherapeutics in august 2012 to help patients combat cancer, kidney disease and other illnesses. our research is based on groundbreaking discoveries regarding the ability of activin, myostatin and other growth factors to change the course of disease progression. our goal is to help patients such as atara ciechanover, our company’s namesake, who suffered from cancer before passing away in 2012. we aim to empower patients to fight their illnesses with better treatment options. atara biotherapeutics is developing several innovative product candidates, including pinta 745, stm 434 and ata 842, and is collaborating with memorial sloan kettering cancer center (msk) in the development of three t-cell product candidates: epstein-barr virus (ebv)-targeted cytotoxic t lymphocytes (ctls), cytomegalovirus (cmv)-targeted ctls, and wilms tumor 1 (wt1)-targeted ctls. each product candidate is designed to address the underlying mechanisms of disease to treat conditions which have
Organization
Atara Biotherapeutics
Employees
165
CEO
Dr. Anhco Nguyen Ph.D.
Industry
Health Technology

Management People of Atara Biotherapeutics

NameTitle
Dr. Anhco Nguyen Ph.D.
President, CEO & Director
Mr. Eric Hyllengren
Executive VP, COO & CFO
Alex Chapman
Vice President of Corporate Communications & Investor Relations
Ms. Jill Henrich
Executive VP and Global Head of Regulatory Affairs & Quality
Mr. Dan Maziasz
Executive VP & Chief Business Officer
Ms. Rajani Dinavahi M.D.
Senior VP & Chief Medical Officer

Important FAQs about investing in Atara Biotherapeutics from India :

What is Atara Biotherapeutics share price today?

Atara Biotherapeutics share price today stands at $13.33, Open: $12.37 ; Previous Close: $12.20 ; High: $13.39 ; Low: $12.16 ; 52 Week High: $39.50 ; 52 Week Low: $6.50. The stock opens at $12.37, after a previous close of $12.20. The stock reached a daily high of $13.39 and a low of $12.16, with a 52-week high of $39.50 and a 52-week low of $6.50.

Can Indians buy Atara Biotherapeutics shares?

Yes, Indians can invest in the Atara Biotherapeutics (ATRA) from India.

With INDmoney, you can buy Atara Biotherapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Atara Biotherapeutics at zero transaction cost.

How can I buy Atara Biotherapeutics shares from India?

It is very easy to buy Atara Biotherapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Atara Biotherapeutics be purchased?

Yes, you can buy fractional shares of Atara Biotherapeutics with INDmoney app.

What are the documents required to start investing in Atara Biotherapeutics stocks?

To start investing in Atara Biotherapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Atara Biotherapeutics

Today’s highest price of Atara Biotherapeutics (ATRA) is $13.39.

Today’s lowest price of Atara Biotherapeutics (ATRA) is $12.16.

What is today's market capitalisation of Atara Biotherapeutics

Today's market capitalisation of Atara Biotherapeutics ATRA is 76.8M

What is the 52 Week High and Low Range of Atara Biotherapeutics

  • 52 Week High

    $39.50

  • 52 Week Low

    $6.50

What are the historical returns of Atara Biotherapeutics?

  • 1 Month Returns

    8.73%

  • 3 Months Returns

    61.38%

  • 1 Year Returns

    -4.77%

  • 5 Years Returns

    -96.69%

Who is the Chief Executive Officer (CEO) of Atara Biotherapeutics

Dr. Anhco Nguyen Ph.D. is the current Chief Executive Officer (CEO) of Atara Biotherapeutics.